Suppr超能文献

健康个体和 MDR-TB 接触者在使用可能有效预防 MDR-TB 发展的抗结核药物治疗时的不良事件:系统评价。

Adverse events in healthy individuals and MDR-TB contacts treated with anti-tuberculosis drugs potentially effective for preventing development of MDR-TB: a systematic review.

机构信息

Dutch Cochrane Centre, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands.

出版信息

PLoS One. 2013;8(1):e53599. doi: 10.1371/journal.pone.0053599. Epub 2013 Jan 11.

Abstract

A recent systematic review concluded that there is insufficient evidence on the effectiveness to support or reject preventive therapy for treatment of contacts of patients with multidrug resistant tuberculosis (MDR-TB). Whether preventive therapy is favorable depends both on the effectiveness and the adverse events of the drugs used. We performed a systematic review to assess adverse events in healthy individuals and MDR-TB contacts treated with anti-tuberculosis drugs potentially effective for preventing development of MDR-TB. We searched MEDLINE, EMBASE, and other databases (August 2011). Record selection, data extraction, and study quality assessment were done in duplicate. The quality of evidence was assessed using the GRADE approach. Of 6,901 identified references, 20 studies were eligible. Among the 16 studies in healthy volunteers (a total of 87 persons on either levofloxacin, moxifloxacin, ofloxacin, or rifabutin, mostly for 1 week), serious adverse events and treatment discontinuation due to adverse events were rare (<1 and <5%, respectively), but mild adverse events frequently occurred. Due to small sample sizes of the levofloxacin and ofloxacin studies an increased frequency of mild adverse events compared to placebo could not be demonstrated or excluded. For moxifloxacin the comparative results were inconsistent. In four studies describing preventive therapy of MDR-TB contacts, therapy was stopped for 58-100% of the included persons because of the occurrence of adverse events ranging from mild adverse events such as nausea and dizziness to serious events requiring treatment. The quality of the evidence was very low. Although the number of publications and quality of evidence are low, the available evidence suggests that shortly after starting treatment the occurrence of serious adverse events is rare. Mild adverse events occur more frequently and may be of importance because these may provoke treatment interruption.

摘要

最近的一项系统评价得出结论,没有足够的证据支持或反对预防性治疗来治疗耐多药结核病(MDR-TB)患者的接触者。预防性治疗是否有利取决于所用药物的有效性和不良反应。我们进行了一项系统评价,以评估使用可能有效预防 MDR-TB 发展的抗结核药物治疗健康个体和 MDR-TB 接触者的不良反应。我们检索了 MEDLINE、EMBASE 和其他数据库(2011 年 8 月)。记录选择、数据提取和研究质量评估均由两人进行。使用 GRADE 方法评估证据质量。在 6901 篇鉴定的参考文献中,有 20 项研究符合条件。在 16 项健康志愿者研究中(总共 87 人接受左氧氟沙星、莫西沙星、氧氟沙星或利福布汀治疗,大多数疗程为 1 周),严重不良事件和因不良事件而停药的发生率较低(分别为<1%和<5%),但轻度不良事件经常发生。由于左氧氟沙星和氧氟沙星研究的样本量较小,无法证明或排除与安慰剂相比轻度不良事件的频率增加。对于莫西沙星,比较结果不一致。在四项描述 MDR-TB 接触者预防性治疗的研究中,由于不良反应的发生,包括恶心、头晕等轻度不良反应和需要治疗的严重事件,治疗被停止,纳入的人员中有 58-100%。证据的质量非常低。尽管出版物的数量和证据的质量都较低,但现有证据表明,在开始治疗后不久,严重不良事件的发生很少见。轻度不良反应更常见,可能很重要,因为这些不良反应可能会导致治疗中断。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cea3/3543458/a5c2608895bf/pone.0053599.g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验